Aap Implantate AG (ETR:AAQ) | Finanzwire

Basculer en Français

9473	Companies
185423	Keywords
117773	Articles
99292	Press releases

Home
Companies
Aap Implantate AG

BRIEF

published on 08/14/2024 at 19:20, 1 year 3 months ago

Aap Implantate AG Reports Balanced EBITDA for H1/2024

EBITDA Cash Flow Sales Growth Financial Outlook Trauma Division
PRESS RELEASE

published on 08/14/2024 at 19:15, 1 year 3 months ago

Half-year financial statements close with balanced EBITDA, Trauma with positive EBITDA
aap Implantate AG reports balanced EBITDA with positive results in trauma business for the first half of 2024. Sales increased by 10% to EUR 6.4 million, driven by EMEA region growth. Key figures include stable gross margin and improved EBITDA

Financial Results EBITDA Medical Technology Sales Growth Aap Implantate AG
BRIEF

published on 07/15/2024 at 07:35, 1 year 4 months ago

Aap Implantate AG Reports Positive Sales Growth for Q2 and H1 2024

Medical Technology Sales Growth Clinical Trials Market Expansion Regional Performance
PRESS RELEASE

published on 07/15/2024 at 07:30, 1 year 4 months ago

Sales growth Q2/2024 +14 % and H1/2024 +10 % compared to previous year; positive development in all operating areas
aap Implantate AG reports sales growth of 14% in Q2/2024 and 10% in H1/2024 compared to the previous year, with positive developments across all operating regions

Sales Growth Aap Implantate AG Antibacterial Implant Technology Q2/2024 H1/2024
BRIEF

published on 05/23/2024 at 19:10, 1 year 6 months ago

Aap Implantate AG Completes Amendment to Bond Terms, Allows Conversion to Shares

Shares Financial News Aap Implantate AG Bonds Conversion
PRESS RELEASE

published on 05/23/2024 at 19:05, 1 year 6 months ago

Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares
aap Implantate AG completes amendment of bond terms allowing bondholders to convert bonds into shares. Conversion period until May 29, 2024. For more information, visit https://www.aap.de/investoren/wandelschuldverschreibung

Medical Technology Investment Aap Implantate AG Bond Amendment Conversion Into Shares
BRIEF

published on 04/22/2024 at 07:35, 1 year 7 months ago

Aap Implantate AG Reports 5.6% Sales Growth in Q1 2024

Aap Implantate AG Financial Growth Q1 2024 Sales Antibacterial Implant Technology MDR Authorization
PRESS RELEASE

published on 04/22/2024 at 07:30, 1 year 7 months ago

aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
aap Implantate AG reports 5.6% sales growth in Q1 2024, positive developments across all regions & progress in human clinical trial of antibacterial implant technology

Sales Growth Clinical Trial Aap Implantate AG Q1 2024 Antibacterial Technology
BRIEF

published on 04/19/2024 at 07:35, 1 year 7 months ago

Aap Implantate AG Announces Successful 10% Capital Increase

Medical Technology Capital Increase Aap Implantate AG Financial Strategy Antibacterial Implant Technology
PRESS RELEASE

published on 04/19/2024 at 07:30, 1 year 7 months ago

aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
aap Implantate AG successfully completes 10% capital increase at EUR 1.10, raising EUR 986,311.70 for human clinical trial of antibacterial implant technology

Capital Increase Authorized Capital Clinical Trial Aap Implantate AG Antibacterial Implant Technology

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 26 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 31 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 1 minute ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 56 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 1 minute ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 09:40, 20 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 31 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 55 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 1 hour 1 minute ago

SPECTRIS PLC - Removal

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 16 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 1 minute ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 16 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 16 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE